MDS/MPN CROSSOVER SYNDROMES
Clinical trials for MDS/MPN CROSSOVER SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MDS/MPN CROSSOVER SYNDROMES trials appear
Sign up with your email to follow new studies for MDS/MPN CROSSOVER SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Low-Dose cocktail aims to outsmart MDS resistance
Disease control Recruiting nowThis early study tests a new way of giving two FDA-approved drugs (5-azacitidine and decitabine) for myelodysplastic syndromes (MDS), a type of bone marrow failure. Instead of standard doses, the drugs are given at low doses on alternating weeks to try to overcome resistance. Abo…
Matched conditions: MDS/MPN CROSSOVER SYNDROMES
Phase: EARLY_PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: MDS/MPN CROSSOVER SYNDROMES
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC